Clin-e-cal Secures Funds to Enhance Smart Asthma Treatment

MedTech Outlook | Thursday, October 15, 2020

A British startup has raised more than £130,000 to commercialize and scale its smart inhaler monitoring technology.

FREMONT, CA: Clin-e-calis a British digital health startup that has secured more than £130,000throughthe high performing crowdfunding platform. The company would want to use the raised funds to commercialize and upscale its smart inhaler monitoring technology. Clin-e-calis looking to help and support asthma patients in the U.K. by developing a smart and high tech medical device and technology platform.

The smartphone apps developed by the company make use of its exceptional and proprietary SoundResponse® technology. This tech conceptualization helps in analyzing the sound signals that are present in the inhaler. The app would then use the inference derived from the sound to generate and provide realistic and instantaneous visual feedback to the users. The report acts as a guide that helps the asthma patients improvise their inhalation technique and also track their adherence.

Clin-e-calis excited to not only upscale its Rafi-Tone, an existing smartphone app but commercialize its new Clip-Tone app technology as well, in order to help around 5.4 million asthma patients in the U.K. to treat their respiratory diseases. Believing that the innovative technology is sure to bring about a change in the inhaler technique as well as the respiratory disease outcomes, the company is looking forward to rolling out its innovation and make it reach all the corners of the world.

Clin-e-cal is a British digital health company, which is formed out from the University of Manchester and Manchester Foundation Trust. The company has its unique SoundResponse® technology patented and further, with an evidence-based approach, looks to accentuate its apps and address the practical needs in the respiratory line of healthcare.